文献速递母胎医学产科

微阵列分析对胎儿右锁骨下动脉迷走无额外价值:268例妊娠描述及系统文献综述

Microarray analysis has no additional value in fetal aberrant right subclavian artery: description of 268 pregnancies and systematic literature review.
PubMed 文献 · Ultrasound Obstet Gynecol · 2019-01-01

回顾性分析2013至2017年以色列卫生部数据库中因胎儿右锁骨下动脉迷走(ARSA)行染色体微阵列分析(CMA)的妊娠,孤立性ARSA 246例中临床显著CMA发现率0.4%(1例21三体),与2752例低危对照无显著差异(P=0.1574)。非孤立性ARSA 22例中21三体1例(4.5%),相对危险度5.5(95%CI 0.8-37.6)。文献汇总579例孤立性ARSA中21三体13例(2.2%),无22q11.2微缺失。

要点

  • 孤立性ARSA的CMA临床显著发现率0.4%,与低危对照无显著差异(P=0.1574)。
  • 非孤立性ARSA的21三体频率与对照无显著差异(相对危险度5.5,95%CI 0.8-37.6)。
  • 汇总579例孤立性ARSA中21三体13例(2.2%),无22q11.2微缺失。

核心结论

  • 非孤立性ARSA与唐氏综合征之间可能存在关联,但孤立性ARSA或许更适合作为唐氏综合征的软指标,而非侵入性产前检测的常规指征。

研究设计与样本

  • 回顾性研究,数据来自以色列卫生部计算机数据库,纳入2013至2017年因超声诊断胎儿ARSA而转诊行侵入性检测和CMA的全部妊娠。
  • 对照为2752例超声和血清筛查结果正常的低危妊娠。
  • 文献检索PubMed自建库至2018年2月,纳入描述孤立性ARSA胎儿微观和亚微观异常频率与性质的英文原创研究。

主要发现

  • 246例孤立性ARSA行CMA分析中,检出临床显著发现1例(0.4%),为21三体,与对照人群无显著差异(P=0.1574)。
  • 22例非孤立性ARSA中另检出21三体1例(4.5%),该队列21三体频率与对照人群无显著差异(相对危险度5.5,95%CI 0.8-37.6)。
  • 文献检索额外获得13篇相关论文,涵盖333例孤立性ARSA病例。
  • 包括本研究在内的579例总体中,检出21三体13例(2.2%),未检出22q11.2微缺失病例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Fetal aberrant right subclavian artery (ARSA) is a relatively common sonographic finding. Several studies have reported a significant association between ARSA and Down syndrome, as well as 22q11.2 microdeletion. The objective of this study was to assess the risk of abnormal chromosomal microarray analysis (CMA) findings in a large cohort of pregnancies with fetal ARSA as an isolated, as well as a non-isolated, sonographic anomaly. A secondary objective was to review the literature, examining the frequency of chromosomal microarray aberrations in fetuses with isolated ARSA. METHODS: Data from all pregnancies referred for invasive testing and CMA due to sonographic diagnosis of fetal ARSA, between 2013 and 2017, were obtained retrospectively from the computerized database of the Israeli Ministry of Health. The rate of clinically significant CMA findings in these fetuses was compared to that in a local control population of 2752 low-risk pregnancies with normal ultrasound and serum screening results. In addition, a literature search was conducted in PubMed, from inception to February 2018, of original studies in the English language describing the frequency and nature of microscopic and submicroscopic aberrations in fetuses with isolated ARSA. RESULTS: Of 246 pregnancies with isolated ARSA that underwent CMA analysis, a clinically significant finding was detected in one (0.4%) pregnancy (trisomy 21). This rate did not differ significantly from that in the control population (P = 0.1574). Of 22 fetuses with non-isolated ARSA, one (4.5%) additional case of trisomy 21 was noted. The frequency of trisomy 21 in this cohort also did not differ from that in the control population (relative risk, 5.5 (95% CI, 0.8-37.6)). The literature search yielded 13 additional relevant papers, encompassing 333 cases of isolated ARSA. Of 579 cases overall (including those of the present study), 13 (2.2%) cases of trisomy 21 were detected, with no cases of 22q11.2 microdeletion. CONCLUSION: While an association may exist between non-isolated ARSA and Down syndrome, isolated ARSA might better serve as a soft marker for Down syndrome, rather than a routine indication for invasive prenatal testing. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Sagi-Dain L, Singer A, Josefsberg S, et al. Microarray analysis has no additional value in fetal aberrant right subclavian artery: description of 268 pregnancies and systematic literature review. Ultrasound Obstet Gynecol. 2019. PMID: 30584678. doi:10.1002/uog.20208

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。